Cargando…
Novel piperazine–chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation
New piperazine–chalcone hybrids and related pyrazoline derivatives have been designed and synthesised as potential vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors. The National Cancer Institute (NCI) has selected six compounds to evaluate their antiproliferative activity in vitro...
Autores principales: | Ahmed, Marwa F., Santali, Eman Y., El-Haggar, Radwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758046/ https://www.ncbi.nlm.nih.gov/pubmed/33349069 http://dx.doi.org/10.1080/14756366.2020.1861606 |
Ejemplares similares
-
Coumarin–carbazole based functionalized pyrazolines: synthesis, characterization, anticancer investigation and molecular docking
por: Patel, Mrugesh, et al.
Publicado: (2021) -
Novel 1,2,3-Triazole-Coumarin Hybrid Glycosides and Their Tetrazolyl Analogues: Design, Anticancer Evaluation and Molecular Docking Targeting EGFR, VEGFR-2 and CDK-2
por: El-Sayed, Wael A., et al.
Publicado: (2022) -
Design, Synthesis,
and Biological Evaluation Studies
of Novel Naphthalene-Chalcone Hybrids As Antimicrobial, Anticandidal,
Anticancer, and VEGFR-2 Inhibitors
por: Osmaniye, Derya, et al.
Publicado: (2023) -
Synthesis, biological evaluation, and in silico studies of novel chalcone- and pyrazoline-based 1,3,5-triazines as potential anticancer agents
por: Moreno, Leydi M., et al.
Publicado: (2020) -
Chalcones, semicarbazones and pyrazolines as inhibitors of cathepsins B, H and L
por: Raghav, Neera, et al.
Publicado: (2015)